Skip to main content
. Author manuscript; available in PMC: 2019 Apr 1.
Published in final edited form as: Cancer. 2018 Jan 9;124(7):1507–1515. doi: 10.1002/cncr.31227

FIGURE 2.

FIGURE 2

FIGURE 2

FIGURE 2

FIGURE 2

Among hematopoietic cell transplant survivors without prior ischemic heart disease (n=2,198), the cumulative incidence of ischemic heart disease over 5-years, stratified by the number of A) cardiovascular risk conditions and B) adverse lifestyle factors, and the cumulative incidence of overall mortality stratified by the number of C) cardiovascular risk conditions and D) adverse lifestyle factors. Global differences in incidence determined by Fine-Gray method (ischemic heart disease) or log-rank (overall mortality).